Skip to main content

Advertisement

SpringerLink
Log in

Psychotic Symptoms in Frontotemporal Dementia

  • Behavior (HS Kirshner, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Although psychotic features have long been recognized in association with frontotemporal dementia (FTD), recent genetic discoveries enabling further subtyping of FTD have revealed that psychotic symptoms are frequent in some forms of FTD. Hallucinations and delusions can even precede onset of other cognitive or behavioural symptoms in patients with FTD. In this review, we explore the frequency and types of psychotic symptoms reported in patients with FTD, as well as in other neuropsychiatric disorders, to aid practitioners’ consideration of these features in the diagnosis of FTD and related disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Gustafson L, Risberg J. Delusions and hallucinations in old age. In: Katona C, Lewy R, editors. Delusions and hallucinations in old age. London: Gaskell; 1992. p. 218–29.

    Google Scholar 

  2. Lillo P et al. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67(7):826–30.

    Article  PubMed  Google Scholar 

  3. Sha SJ et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology. 2012;79(10):1002–11. This is one of the seminal papers describing the most common presenting symptoms, including psychosis, in a cohort of patients with FTD and C9ORF72 mutations.

    Article  PubMed Central  PubMed  Google Scholar 

  4. van Blitterswijk M et al. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol Neurodegener. 2014;9:38.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Snowden JS et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135(Pt 3):693–708. This report describes a large cohort of patients with FTD and provides excellent detailed descriptions of psychotic symptoms in FTD patients with and without C9ORF72 mutations.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Schoder D et al. Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry. 2010;197(1):28–35.

    Article  PubMed  Google Scholar 

  7. Landqvist Waldo M et al. Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma? Int Psychogeriatr. 2015;27(4):531–9. This is one of the largest autopsy-confirmed studies to date to examine correlations between the presence and type of psychotic symptoms and patterns of atrophy in 97 consecutive patients with confirmed FTLD.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Omar R et al. Delusions in frontotemporal lobar degeneration. J Neurol. 2009;256(4):600–7.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Le Ber I et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131(Pt 3):732–46.

    Article  PubMed  Google Scholar 

  10. Bathgate D et al. Behaviour in frontotemporal dementia, Alzheimer’s disease and vascular dementia. Acta Neurol Scand. 2001;103(6):367–78.

    Article  CAS  PubMed  Google Scholar 

  11. Kertesz A et al. Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cogn Behav Neurol. 2013;26(3):146–54.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Harciarek M, Kertesz A. The prevalence of misidentification syndromes in neurodegenerative diseases. Alzheimer Dis Assoc Disord. 2008;22(2):163–9.

  13. Leger GC, Banks SJ. Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia. Dement Geriatr Cogn Disord. 2014;37(1-2):104–12.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Mendez MF et al. Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology. 2013;80(6):561–8.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Mahoney CJ et al. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res Ther. 2012;4(5):41.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Hsiung GY et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135(Pt 3):709–22.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Dobson-Stone C et al. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology. 2012;79(10):995–1001.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Boeve BF, Graff-Radford NR. Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther. 2012;4(4):29.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Le Ber I. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm. Rev Neurol (Paris). 2013;169(10):811–9.

    Article  Google Scholar 

  20. Boeve BF et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135(Pt 3):765–83.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Cruts M, Kumar-Singh S, Van Broeckhoven C. Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Curr Alzheimer Res. 2006;3(5):485–91.

    Article  CAS  PubMed  Google Scholar 

  22. Chen-Plotkin AS et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68(4):488–97.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Le Ber I et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat. 2007;28(9):846–55.

    Article  PubMed  Google Scholar 

  24. Seelaar H et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011;82(5):476–86.

    Article  PubMed  Google Scholar 

  25. Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol. 2012;8(8):423–34.

    PubMed Central  CAS  PubMed  Google Scholar 

  26. Khan BK et al. Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman. Psychosomatics. 2012;53(3):280–4.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Velakoulis D et al. Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry. 2009;194(4):298–305.

    Article  CAS  PubMed  Google Scholar 

  28. Mendez MF et al. Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement Geriatr Cogn Disord. 2008;25(3):206–11.

    Article  PubMed  Google Scholar 

  29. Passant U et al. Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Alzheimer Dis Assoc Disord. 2005;19 Suppl 1:S15–8.

    Article  PubMed  Google Scholar 

  30. Harciarek M et al. Schizophrenia and frontotemporal dementia: shared causation? Int Rev Psychiatry. 2013;25(2):168–77.

    Article  PubMed  Google Scholar 

  31. Pose M et al. The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood. Int Rev Psychiatry. 2013;25(2):159–67.

    Article  PubMed  Google Scholar 

  32. Momeni P et al. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin Neurol Neurosurg. 2010;112(10):917–20.

    Article  PubMed  Google Scholar 

  33. Momeni P et al. Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia. Neurocase. 2010;16(3):273–9.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Yoshino, Y., et al., No abnormal hexanucleotide repeat expansion of C9ORF72 in Japanese schizophrenia patients. J Neural Transm, 2014.

  35. Huey ED et al. C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiol Aging. 2013;34(4):1309 e9–10.

    Article  Google Scholar 

  36. Galimberti D et al. C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiol Aging. 2014;35(5):1214.e7–10.

    Article  CAS  Google Scholar 

  37. Cooper JJ, Ovsiew F. The relationship between schizophrenia and frontotemporal dementia. J Geriatr Psychiatry Neurol. 2013;26(3):131–7.

    Article  PubMed  Google Scholar 

  38. Harris MJ, Jeste DV. Late-onset schizophrenia: an overview. Schizophr Bull. 1988;14(1):39–55.

    Article  CAS  PubMed  Google Scholar 

  39. Shenton ME et al. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49(1-2):1–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Snowden JS et al. Psychosis, C9ORF72 and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2012;83(10):1031–2.

    Article  PubMed  Google Scholar 

  41. McKeith I. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(3 Suppl):417–23.

    PubMed  Google Scholar 

  42. Engelborghs S et al. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry. 2005;20(11):1028–37.

    Article  PubMed  Google Scholar 

  43. Craig D et al. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer’s disease. Am J Geriatr Psychiatr. 2005;13(6):460–8.

    Article  Google Scholar 

  44. Paulsen JS et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000;54(10):1965–71.

    Article  CAS  PubMed  Google Scholar 

  45. Tariot PN et al. The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer’s disease. The behavioral pathology committee of the consortium to establish a registry for Alzheimer’s disease. Am J Psychiatry. 1995;152(9):1349–57.

    Article  CAS  PubMed  Google Scholar 

  46. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease. I: disorders of thought content. Br J Psychiatry. 1990;157:72–6.

  47. Mendez MF et al. False reports from patients with frontotemporal dementia: delusions or confabulations? Behav Neurol. 2011;24(3):237–44.

    Article  PubMed  Google Scholar 

  48. Chan D et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132(Pt 5):1287–98.

    Article  PubMed  Google Scholar 

  49. Bruen PD et al. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain. 2008;131(Pt 9):2455–63.

    Article  PubMed  Google Scholar 

  50. Whitehead D et al. Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer’s disease. Int Psychogeriatr. 2012;24(1):99–107.

    Article  CAS  PubMed  Google Scholar 

  51. Serra L et al. Are the behavioral symptoms of Alzheimer’s disease directly associated with neurodegeneration? J Alzheimers Dis. 2010;21(2):627–39.

    PubMed  Google Scholar 

  52. Ismail Z et al. Neuroimaging of delusions in Alzheimer’s disease. Psychiatry Res. 2012;202(2):89–95.

    Article  PubMed  Google Scholar 

  53. Mendez MF, Ramirez-Bermudez J. Cotard syndrome in semantic dementia. Psychosomatics. 2011;52(6):571–4.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Gramaglia C et al. Early onset frontotemporal dementia with psychiatric presentation due to the C9ORF72 hexanucleotide repeat expansion: a case report. BMC Neurol. 2014;14(1):228.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Kobayashi T et al. Effectiveness of electroconvulsive therapy for depression and Cotard’s syndrome in a patient with frontotemporal lobe dementia. Case Rep Psychiatry. 2012;2012:627460.

    PubMed Central  PubMed  Google Scholar 

  56. Pijnenburg YA et al. Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. Int J Geriatr Psychiatry. 2003;18(1):67–72.

    Article  CAS  PubMed  Google Scholar 

  57. Arighi A et al. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J Alzheimers Dis. 2012;31(2):447–52.

    PubMed  Google Scholar 

  58. Loy CT et al. The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol. 2010;6(3):175–9.

    Article  PubMed  Google Scholar 

  59. Arosio B et al. GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype. J Alzheimers Dis. 2013;35(4):669–74.

  60. American Psychiatric Association. Diagnostic and statistical manual of mental disorders fifth edition. Washington, DC: American Psychiatric Publishing; 2013.

  61. Caliyurt O et al. Cotard’s syndrome with schizophreniform disorder can be successfully treated with electroconvulsive therapy: case report. J Psychiatry Neurosci. 2014;29(2):138–41.

  62. Debruyne H et al. Cotard’s syndrome: a review. Curr Psychiatry Rep. 2009;11(3):197–202.

  63. Langdon R et al. The Fregoli delusion: a disorder of person identification and tracking. Top Cogn Sci. 2014;6(4):615–31.

  64. Simon-Sanchez J et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135(Pt 3):723–35.

  65. Tartaglia MC et al. Delusions and hallucinations in frontotemporal dementia: a clinicopathologic case report. Cogn Behav Neurol. 2008;21(2):107–10.

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

The authors declare that they have no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada

    Devin Hall & Elizabeth C. Finger

  2. Lawson Health Research Institute, London, ON, Canada

    Devin Hall & Elizabeth C. Finger

  3. University Hospital, University of Western Ontario, 301 Windermere Rd, London, ON, N6A 5A5, Canada

    Elizabeth C. Finger

Authors
  1. Devin Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth C. Finger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth C. Finger.

Additional information

This article is part of the Topical Collection on Behavior

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hall, D., Finger, E.C. Psychotic Symptoms in Frontotemporal Dementia. Curr Neurol Neurosci Rep 15, 46 (2015). https://doi.org/10.1007/s11910-015-0567-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-015-0567-8

Keywords

Search

Navigation